PTC R&D increased by 3.5% to $124.13M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 11.8%, from $111.02M to $124.13M. Over 4 years (FY 2021 to FY 2025), R&D shows an upward trend with a 11.1% CAGR.
Analysis
StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2014
Last reportedQ2 2026May 7, 2026
How to read this metric
Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.
Detailed definition
Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...
Peer comparison
Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.
Metric ID:
research_and_developmentHistorical Data
20 periods
| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $78.13M | $78.40M | $80.53M | $81.94M | $88.17M | $88.18M | $88.18M | $100.35M | $103.82M | $102.03M | $105.78M | $107.00M | $110.25M | $110.01M | $115.52M | $111.02M | $116.65M | $114.51M | $119.98M | $124.13M |
| QoQ Change | — | +0.3% | +2.7% | +1.7% | +7.6% | +0.0% | -0.0% | +13.8% | +3.5% | -1.7% | +3.7% | +1.1% | +3.0% | -0.2% | +5.0% | -3.9% | +5.1% | -1.8% | +4.8% | +3.5% |
| YoY Change | — | — | — | — | +12.8% | +12.5% | +9.5% | +22.5% | +17.7% | +15.7% | +20.0% | +6.6% | +6.2% | +7.8% | +9.2% | +3.8% | +5.8% | +4.1% | +3.9% | +11.8% |
Range$78.13M – $124.13M
CAGR+10.2%
Avg YoY Growth+10.6%
Median YoY Growth+9.3%
Current Streak2 quarters growth
R&D at Other Companies
Frequently Asked Questions
- What is PTC's r&d?
- PTC (PTC) reported r&d of $124.13M in Q1 2026.
- How has PTC's r&d changed year-over-year?
- PTC's r&d increased by 11.8% year-over-year, from $111.02M to $124.13M.
- What is the long-term trend for PTC's r&d?
- Over 4 years (2021 to 2025), PTC's r&d has grown at a 11.1% compound annual growth rate (CAGR), from $299.92M to $457.69M.
- What does r&d mean?
- The money spent on creating new products or improving existing ones to drive future growth.